VR Logo

AtriCure Inc. (ATRC) download report


Healthcare | Medical Devices & Equipment

AtriCure Inc. (ATRC) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally.

IPO Date: 05-Aug-2005

CEO, Pres & Director: Mr. Michael H. Carrel

Chief Financial Officer: Ms. Angela L. Wirick CPA

Listing: NASDAQ: ATRC

Country: United States

Headquarters: Mason, OH

Website: https://www.atricure.com

Key Facts

Market cap: $1,835.78 Mln

Revenue (TTM): $289.63 Mln

Earnings (TTM): $51.93 Mln

Cash: $111.40 Mln

Total Debt: $75.32 Mln

Insider's Holding: 2.81%

Liquidity: Low

52 Week range: $34.30 - 89.18

Shares outstanding: 46,287,900

10 Years Aggregate:

  • CFO: $-114.29 Mln
  • EBITDA: $-79.96 Mln
  • Net Profit: $-176.94 Mln

Stock Performance

Time Period AtriCure (ATRC) S&P BSE Sensex S&P Small-Cap 600
YTD-42.18-8.99-19.87
1 month-4.47-3.40-10.07
3 months-37.77-8.50-17.25
1 Year-49.310.89-18.01
3 Years10.4410.415.62
5 Years10.2811.435.60
10 Years15.3911.779.69
As on 30-Jun-2022
Year AtriCure (ATRC) S&P Small-Cap 600 S&P BSE Sensex
202124.9025.2721.99
202071.249.5715.75
20196.2420.8614.38
201867.29-9.705.87
2017-6.8011.7327.91
2016-12.7924.741.95
201512.42-3.36-5.03